≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Defects in the complement system

DOID Endpoint Browser PheWeb

D3_COMPLEMENTDEF

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D84.1
  • Hospital discharge: ICD-9 — 2798B
  • Cause of death: ICD-10 — D84.1
  • Cause of death: ICD-9 — 2798B

2 out of 7 registries used, show all original rules.

250

4. Check minimum number of events

None

250

5. Include endpoints

None

250

6. Filter based on genotype QC (FinnGen only)

250

Control definitions (FinnGen only)

Control exclude
D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D84
Name in latin
Deficientia systematis complementi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1516 980 531
Only index persons 1328 892 436
Unadjusted period prevalence (%)
Whole population 0.02 0.03 0.01
Only index persons 0.03 0.03 0.02
Median age at first event (years)
Whole population 36.99 41.26 28.98
Only index persons 40.75 42.47 37.23

-FinnGen-

Key figures

All Female Male
Number of individuals 250 187 63
Unadjusted period prevalence (%) 0.05 0.06 0.03
Median age at first event (years) 45.47 45.49 45.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
221
Matched controls
2209
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
116.2
101
*
D84.1
ICD-10 Finland
Defects in the complement system
+∞
69.5
63
*
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
63.7
58
*
T78.3
ICD-10 Finland
Angioneurotic oedema
101.2
50.6
54
7
H02AB06
ATC
prednisolone; systemic
6.8
37.5
163
646
D84.11
ICD-10 Finland
Hereditary angioedema type I
+∞
34.3
32
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.4
30.4
140
535
338
Kela drug reimbursment
C1-esterase inhibitor, icatibant and conestat alfa
+∞
29.9
28
*
D84.13
ICD-10 Finland
Hereditary angioedema type III
+∞
27.7
26
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
12.4
27.4
51
52
B06AC02
ATC
icatibant; parenteral
+∞
25.5
24
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
24.4
23
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.8
23.7
102
336
R03DC03
ATC
montelukast; oral
5.4
23.2
83
223
C01CA24
ATC
epinephrine; parenteral
8.4
23.1
54
82
ZX120
NOMESCO Finland
Intravenous
7.1
21.4
56
100
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
21.2
20
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
20.1
19
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
20.1
19
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
20.1
19
*
B02AA02
ATC
tranexamic acid; systemic
4.8
19.4
76
219
H02AB09
ATC
hydrocortisone; systemic
11.5
17.6
33
33
WW200
NOMESCO Finland
Immunization
15.8
17.3
28
20
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.6
16.2
63
177
TPH04
NOMESCO Finland
Cathetrisation of vein
4.0
15.6
74
249
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.8
15.3
31
36
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
11.7
15.2
28
27
UJF32
NOMESCO Finland
Coloscopy
3.8
14.9
76
268
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
14.7
14
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.8
14.7
75
264
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
6.0
14.1
40
78
H02AB07
ATC
prednisone; oral
4.4
14.0
56
159
R50.9
ICD-10 Finland
Fever, unspecified
4.0
13.9
63
201
D84.12
ICD-10 Finland
Hereditary angioedema type II
+∞
13.7
13
*
J01MA14
ATC
moxifloxacin; systemic
5.9
13.6
39
77
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.7
13.4
48
122
J45.9
ICD-10 Finland
Asthma, unspecified
3.6
13.4
71
258
XQ800
NOMESCO Finland
Prick test
4.7
12.9
47
121
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.2
12.8
53
155
R60.9
ICD-10 Finland
Oedema, unspecified
8.9
12.8
27
34
R03AC02
ATC
salbutamol; inhalant
2.9
12.7
151
940
UDH02
NOMESCO Finland
Rhinopharyngoscopy
6.3
12.6
34
62
J47
ICD-10 Finland
Bronchiectasis
22.9
12.2
17
8
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.9
12.0
27
38
R60.0
ICD-10 Finland
Localized oedema
4.9
11.7
40
96
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
11.6
107
557
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
11.6
11
*
J01FA06
ATC
roxithromycin; oral
2.8
11.6
101
508
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.5
11.5
22
23
J45.1
ICD-10 Finland
Nonallergic asthma
4.9
11.5
39
93
R06AE07
ATC
cetirizine; oral
2.7
11.4
124
711
H02AB04
ATC
methylprednisolone; systemic
3.7
11.2
53
173
R06.0
ICD-10 Finland
Dyspnoea
3.1
11.2
71
290
WZC30
NOMESCO Finland
Teaching
3.9
11.1
48
145
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.4
10.8
59
216
X59
ICD-10 Finland
Exposure to unspecified factor
3.1
10.6
68
279
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
4.4
10.5
39
102
B06AC01
ATC
c1-inhibitor, plasma derived; parenteral
+∞
10.5
10
*
B06AC05
ATC
lanadelumab; parenteral
+∞
10.5
10
*
T78.4
ICD-10 Finland
Allergy, unspecified
5.9
10.4
29
55
R03BB04
ATC
tiotropium bromide; inhalant
5.5
10.4
31
64
J01MA02
ATC
ciprofloxacin; systemic
2.7
10.3
91
451
J31.0
ICD-10 Finland
Chronic rhinitis
4.5
10.3
37
94
UJF92
NOMESCO Finland
Capsular endoscopy
9.9
10.3
20
22
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.2
10.0
31
67
R06AE09
ATC
levocetirizine; oral
3.3
9.8
55
204
R01AD08
ATC
fluticasone; nasal
2.7
9.8
85
417
R06AX27
ATC
desloratadine; oral
2.6
9.7
95
496
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
9.7
82
395
UJF30
NOMESCO Finland
Ileoscopy through colon
4.2
9.6
37
100
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.3
9.5
36
96
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.1
9.3
55
211
X57
ICD-10 Finland
Unspecified privation
12.2
9.2
16
14
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.2
9.1
28
60
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.4
9.0
142
945
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.2
9.0
50
184
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
11.4
8.9
16
15
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
8.9
96
524
L50.9
ICD-10 Finland
Urticaria, unspecified
6.3
8.9
23
40
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
8.9
62
265
C03CA01
ATC
furosemide; systemic
3.1
8.8
52
197
J01MA12
ATC
levofloxacin; systemic
3.1
8.8
52
198
R03BA02
ATC
budesonide; inhalant
2.9
8.7
59
247
ZXA10
NOMESCO Finland
Bilateral
3.0
8.7
53
207
Z31.5
ICD-10 Finland
Genetic counselling
4.5
8.7
31
78
A02BC01
ATC
omeprazole; systemic
2.7
8.6
72
340
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
8.6
78
385
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
28.8
8.6
11
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.0
8.3
26
57
J01FA10
ATC
azithromycin; systemic
2.4
8.3
156
1107
C08DA01
ATC
verapamil; systemic
10.6
8.2
15
15
6BA02
NOMESCO Finland
NA
34.7
8.1
10
*
Z3231
NOMESCO Finland
Registered nurse
2.5
8.1
81
419
J05AB11
ATC
valaciclovir; oral
3.2
8.1
44
157
G47.3
ICD-10 Finland
Sleep apnoea
2.9
8.1
52
210
Z3226
NOMESCO Finland
Physiotherapist
2.7
8.0
61
273
R51.80
ICD-10 Finland
Headache
2.9
8.0
54
222
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.5
8.0
23
46
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.9
7.9
25
56
P01BA02
ATC
hydroxychloroquine; oral
3.8
7.9
33
97
N06AX21
ATC
duloxetine; oral
3.4
7.8
39
132
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.5
7.8
70
343
R53
ICD-10 Finland
Malaise and fatigue
2.7
7.7
56
243
J01FF01
ATC
clindamycin; systemic
2.5
7.6
71
353
R03AK08
ATC
formoterol and beclometasone; inhalant
6.4
7.6
19
32
R03BA05
ATC
fluticasone; inhalant
2.6
7.6
62
287
ZYC01
NOMESCO Finland
Remote contact by phone
4.9
7.5
24
54
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
7.5
57
252
L04AB04
ATC
adalimumab; parenteral
9.9
7.4
14
15
M25.5
ICD-10 Finland
Pain in joint
2.4
7.4
75
389
G03XA01
ATC
danazol; oral
+∞
7.3
7
*
4AA12
NOMESCO Finland
NA
31.1
7.2
9
*
L04AX01
ATC
azathioprine; systemic
5.5
7.1
20
39
Z2445
NOMESCO Finland
Psychologist
4.2
7.1
26
68
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.5
7.0
32
101
J45
ICD-10 Finland
Asthma
3.3
7.0
35
119
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.3
7.0
25
64
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
7.1
7.0
16
24
A01AB09
ATC
miconazole; local oral
3.5
6.9
32
102
B34.9
ICD-10 Finland
Viral infection, unspecified
6.0
6.9
18
32
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
6.9
45
180
R01AD09
ATC
mometasone; nasal
2.1
6.8
117
767
R03AK07
ATC
formoterol and budesonide; inhalant
2.5
6.8
60
289
R03DA04
ATC
theophylline; systemic, rectal
6.3
6.8
17
29
V18
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident
23.3
6.7
9
*
R03BA08
ATC
ciclesonide; inhalant
3.6
6.7
29
88
N05BA01
ATC
diazepam; systemic, rectal
3.0
6.7
38
141
XA800
NOMESCO Finland
Neuropsychological investigation
4.8
6.7
21
47
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.1
6.7
37
134
L50.8
ICD-10 Finland
Other urticaria
9.1
6.6
13
15
K50.9
ICD-10 Finland
Crohn disease, unspecified
10.5
6.6
12
12
N02AX02
ATC
tramadol; systemic, rectal
2.2
6.6
90
532
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
6.6
28
84
A06AC01
ATC
ispaghula (psylla seeds); oral
2.5
6.5
57
273
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
5.2
6.5
19
39
N03AX16
ATC
pregabalin; oral
2.5
6.5
58
279
H25.9
ICD-10 Finland
Senile cataract, unspecified
71.8
6.5
7
*
Z2221
NOMESCO Finland
Medical doctor
2.2
6.4
75
413
C08CA01
ATC
amlodipine; oral
2.4
6.4
62
313
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
18.7
6.3
9
5
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.3
6.3
22
55
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
6.3
6
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
6.3
6
*
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
6.3
6
*
D84.14
ICD-10 Finland
C1 esterase inhibitor deficiency (C1-INH deficiency)
+∞
6.3
6
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
6.1
6.3
16
28
J06.80
ICD-10 Finland
Continuously repeating infections of a child
27.5
6.3
8
*
R42
ICD-10 Finland
Dizziness and giddiness
2.6
6.2
48
214
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.2
6.2
18
37
M79.7
ICD-10 Finland
Fibromyalgia
5.2
6.2
18
37
A06AD11
ATC
lactulose; oral
3.4
6.2
29
94
E0000UV
ATC
NA
2.0
6.2
104
668
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
5.5
6.2
17
33
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
13.0
6.1
10
8
N03AX12
ATC
gabapentin; oral
2.7
6.1
42
177
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.3
6.0
29
96

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
103
77
22.05
117.35
2.4
1.4
g/l
0.2
0.2
3.52
86
77
(4062490)
58
20
37.46
89.50
2.7
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
102
133
12.27
79.89
3.5
1.7
g/l
1.6
1.3
0.22
95
127
(3005719) IgG [Mass/volume] in Serum or Plasma
111
162
11.52
79.82
7.2
2.2
g/l
9.4
10.0
0.66
106
153
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
44
16
33.16
66.14
2.5
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
45
22
24.73
60.62
2.4
1.3
e9/l
1.5
1.2
—
38
6
(42870588) Differential panel, method unspecified - Blood
158
681
4.59
30.90
12.6
6.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
202
1063
5.69
29.94
15.0
6.4
e9/l
0.6
0.5
0.74
196
918
(3006315) Basophils [#/volume] in Blood
202
1065
5.67
29.81
15.0
6.4
e9/l
0.0
0.0
0.45
196
915
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
34
8
48.92
28.55
1.4
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
203
1096
5.53
28.46
15.3
6.9
e9/l
0.2
0.2
0.11
198
965
(3019198) Lymphocytes [#/volume] in Blood
202
1088
5.46
28.37
15.1
6.4
e9/l
2.1
2.1
0.13
197
962
(3037522) Nuclear Ab [Titer] in Serum
92
292
4.40
26.61
1.9
1.4
titre
463.2
544.6
0.24
19
65
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
23
0
+∞
24.37
1.7
0.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
127
547
3.69
23.08
2.9
1.4
g/l
1.7
2.1
2.41
105
322
(3036481) Cortisol [Moles/volume] in Serum or Plasma
70
207
4.31
21.81
3.5
2.1
nmol/l
316.8
361.5
0.90
65
193
(3023419) Bacteria identified in Sputum by Culture
20
15
14.41
21.34
4.8
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
203
1234
4.43
20.86
17.1
9.5
e9/l
4.0
3.9
0.40
198
1064
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
31
9.24
20.51
4.6
3.2
%
58.8
59.1
0.03
26
31
(3030905) Polymorphonuclear cells [#/volume] in Blood
26
31
9.24
20.51
4.7
2.6
e9/l
4.2
4.9
0.55
26
31
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
29
40
8.07
20.37
1.6
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
175
976
3.64
20.24
17.3
8.9
e9/l
0.0
0.0
0.51
152
783
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
23
7
35.97
18.31
3.0
1.3
u/ml
786.8
1447.7
—
23
7
(3023368) Bacteria identified in Blood by Culture
100
417
3.33
18.30
7.2
3.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
119
555
3.18
17.96
10.9
7.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
59
176
4.08
17.91
2.5
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
59
177
4.05
17.76
2.3
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
72
248
3.67
17.76
3.4
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
109
493
3.15
17.20
9.7
4.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
41
6.96
16.17
2.4
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
36
7.27
15.60
2.4
2.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
14
12.14
15.46
4.8
2.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
35
79
4.99
15.02
2.0
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
147
835
2.85
14.63
15.6
7.3
mmol/l
1.2
1.2
1.57
136
764
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
33
7.21
14.27
1.7
1.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
147
850
2.77
13.89
3.5
2.5
nmol/l
77.4
74.1
0.69
139
767
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
127
687
2.72
13.63
6.2
3.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
26
7.83
13.31
1.5
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
59
217
3.25
12.78
3.5
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
36
95
4.26
12.69
4.4
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
41
120
3.89
12.57
2.6
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
95
460
2.72
12.47
5.5
2.4
mg/l
2.9
2.9
0.04
90
399
(3018418) pH of Serum or Plasma
102
513
2.67
12.40
7.1
3.7
ph
7.4
7.4
0.41
22
87
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
42
5.93
12.36
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
42
5.93
12.36
1.3
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
151
919
2.62
12.35
11.5
7.2
mmol/l
1.2
1.2
0.57
130
794
(3002179) Metamyelocytes/100 leukocytes in Blood
45
143
3.62
12.23
5.3
5.2
%
0.5
0.4
0.07
14
32
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
32
6.71
12.20
1.1
1.3
u/ml
1.6
1.5
—
9
11
(3025159) Blasts/100 leukocytes in Blood
44
139
3.63
12.06
5.5
5.8
%
0.0
0.0
0.00
15
39
(3017181) Myelocytes/100 leukocytes in Blood
47
156
3.48
11.95
5.3
5.5
%
0.8
0.8
0.04
18
54
(3026782) Osmolality of Urine
81
373
2.73
11.62
4.5
2.6
mosm/kgh2o
504.1
556.5
1.25
75
317
(3012095) Magnesium [Moles/volume] in Serum or Plasma
66
276
2.89
11.33
6.6
4.9
mmol/l
0.8
0.8
1.00
66
263
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
207
1511
3.15
11.26
15.2
6.7
u/l
78.0
82.1
0.71
201
1411
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
28
6.85
11.25
1.4
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
168
1112
2.56
10.98
11.0
4.7
mmol/l
6.3
6.4
0.54
163
1022
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
14
5
29.51
10.84
1.8
1.0
u/l
11.8
11.6
—
14
5
(3013707) Erythrocyte sedimentation rate by Westergren method
209
1548
3.13
10.79
11.2
3.9
mm/h
11.9
9.9
1.50
203
1439
(3021440) Promyelocytes/100 leukocytes in Blood
43
144
3.40
10.74
5.7
5.8
%
0.0
0.1
1.24
17
45
(44806118)
14
17
8.66
10.72
1.3
1.8
—
—
—
0
0
(44790048)
14
17
8.66
10.72
1.3
1.8
—
—
—
0
0
(44790047)
14
17
8.66
10.72
1.3
1.8
—
—
—
0
0
(44790049)
14
17
8.66
10.72
1.3
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
23
7.36
10.70
1.4
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
128
757
2.42
10.62
8.6
4.8
g/l
36.3
36.7
0.37
121
712
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
155
1001
2.44
10.50
7.8
6.1
umol/l
11.6
12.3
0.16
145
942
(21494814) CD8 cells/100 lymphocytes in Specimen
10
0
+∞
10.49
2.1
0.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
63
267
2.82
10.49
3.3
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
31
85
4.02
10.34
2.3
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
24
7.05
10.31
1.1
1.7
—
—
—
0
0
(4010399)
41
138
3.36
10.14
1.7
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
64
281
2.72
9.91
4.0
2.4
umol/l
11.6
14.2
2.62
64
259
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
98
528
2.41
9.87
3.4
2.0
u/l
121.9
153.7
0.74
93
508
(3027945) Reticulocytes/100 erythrocytes in Blood
51
199
2.96
9.83
5.0
3.7
%
1.7
1.6
0.24
51
189
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
80
397
2.49
9.61
3.8
3.3
ng/l
491.0
815.2
1.22
68
327
(36304419) Bacteria [Presence] in Urine
98
535
2.37
9.52
5.4
3.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
96
3.68
9.40
2.4
1.3
—
—
—
0
0
(4034850)
25
64
4.23
9.11
21.5
6.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
31
5.81
9.10
2.9
2.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
104
592
2.30
9.08
5.4
3.1
e6/l
99.0
61.1
0.20
93
431
(3018095) Leukocytes [#/volume] in Urine
118
708
2.26
9.07
6.2
3.7
e6/l
133.3
39.6
0.41
98
458
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
18
7.56
8.93
3.4
2.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
18
7.56
8.93
3.4
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
18
7.56
8.93
3.4
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
32
5.63
8.81
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
80
3.82
8.81
1.2
1.2
—
—
—
0
0
(3012544) pH of Venous blood
54
232
2.69
8.64
13.7
6.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
22
6.68
8.62
2.4
2.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
19
7.16
8.52
1.5
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
37
5.16
8.50
1.2
1.3
u/ml
3.3
4.2
—
8
18
(3030467) Casts [#/volume] in Urine by Automated count
96
541
2.26
8.47
5.6
3.1
e6/l
0.7
0.3
0.29
84
382
(3052851) Hemolysis interference index of Serum or Plasma
21
50
4.49
8.37
2.8
2.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
47
191
2.80
8.35
16.8
9.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
30
5.63
8.32
2.9
2.1
%
16.8
17.1
—
9
14
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
23
6.39
8.27
1.4
1.8
—
—
—
0
0
(4306422)
15
27
5.85
8.12
1.2
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
36
4.99
7.76
2.6
9.7
u/ml
0.3
0.4
0.36
12
21
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
22
59
3.99
7.53
1.7
1.3
u/ml
7.8
49.1
—
6
6
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
33
5.11
7.52
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
13
22
6.18
7.46
5.2
7.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
48
209
2.60
7.42
1.5
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
81
447
2.20
7.35
3.3
2.3
mg/l
0.9
1.1
0.30
71
335
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
0
+∞
7.32
1.3
0.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
19
6.58
7.31
1.2
1.5
—
—
—
0
0
(3000492) Spirometry study
46
198
2.62
7.27
2.1
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
50
225
2.53
7.22
14.5
6.4
mmol/l
1.6
1.6
0.03
43
170
(3023520) Reticulocytes [#/volume] in Blood
36
138
2.88
7.09
3.0
3.2
e9/l
83.0
73.0
0.72
23
103
(3048689) Calprotectin [Mass/mass] in Stool
64
325
2.30
7.07
5.0
2.6
ug/g
136.5
85.3
0.60
56
254
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
39
157
2.76
7.01
4.2
3.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
50
229
2.48
6.94
4.1
4.2
umol/l
4.5
7.5
1.19
41
203
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
29
101
3.12
6.73
21.0
4.7
%
1.6
1.2
0.70
29
101
(3015736) pH of Urine
119
781
2.00
6.67
5.6
3.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
64
335
2.22
6.53
3.6
3.0
e6/l
0.8
0.8
0.01
44
183
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
29
5.05
6.53
2.4
1.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
15
34
4.63
6.33
3.7
2.4
kpa
9.7
9.1
0.45
15
34
(3013290) Carbon dioxide [Partial pressure] in Blood
15
34
4.63
6.33
3.7
2.4
kpa
4.8
5.0
0.34
15
34
(3020891) Body temperature
22
67
3.50
6.30
17.2
5.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
78
3.30
6.23
1.5
1.3
—
—
—
0
0
(3010421) pH of Blood
16
39
4.31
6.19
3.8
2.5
ph
7.4
7.4
0.09
16
34
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
105
673
1.97
6.18
2.2
1.8
pmol/l
98.9
96.8
0.18
60
333
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
41
181
2.51
6.12
10.1
11.4
mmol/l
24.5
24.8
0.28
41
181
(4268621)
12
23
5.43
6.07
2.3
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
59
3.60
6.00
6.2
1.5
g/l
5.6
3.6
0.66
15
49
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
59
3.60
6.00
6.1
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
52
261
2.25
5.83
1.7
1.7
nmol/l
1510.2
1144.6
1.63
42
200
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
56
3.59
5.71
1.7
1.6
iu/ml
0.0
0.1
—
8
10
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
47
3.81
5.58
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
48
237
2.27
5.58
3.3
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
178
1394
1.96
5.45
7.4
4.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
68
390
2.02
5.38
1.7
1.4
nmol/l
23.0
20.9
0.49
58
332
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
96
621
1.89
5.33
5.4
3.1
ng/l
16.1
25.1
1.11
62
344
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
323
2.08
5.29
3.5
3.1
e6/l
2.2
3.0
0.49
39
175
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
167
2.43
5.26
5.5
7.0
mmol/l
1.0
1.3
0.20
28
121
(3025941) Bacteria identified in Stool by Culture
31
129
2.60
5.21
1.3
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
27
4.62
5.09
1.2
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
96
631
1.85
5.01
3.4
3.0
mmol/l
2.3
2.4
2.74
86
571
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
56
3.39
5.00
1.3
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
37
171
2.37
4.99
5.8
6.9
ph
7.4
7.4
—
7
9
(40761535) Cells panel - Urine sediment
32
139
2.49
4.93
6.4
3.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
37
172
2.35
4.93
5.8
6.9
kpa
5.2
5.1
0.16
37
159
(3003396) Base excess in Arterial blood by calculation
37
172
2.35
4.93
10.2
7.9
mmol/l
1.8
1.4
0.25
32
127
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
173
2.34
4.86
1.7
1.3
iu/ml
43.9
160.8
—
10
76
(3015235) Bicarbonate [Moles/volume] in Capillary blood
15
42
3.74
4.84
3.7
2.9
mmol/l
25.1
25.1
0.01
15
35
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
68
3.11
4.83
1.5
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
74
453
1.90
4.79
2.1
2.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
75
462
1.89
4.76
6.0
3.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
12
29
4.30
4.68
2.3
1.8
mmol/l
1.7
1.5
0.23
12
29
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
73
450
1.88
4.61
2.6
2.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
5
14.34
4.60
2.1
2.2
nmol/l
140.1
128.4
—
7
5
(3032080) INR in Blood by Coagulation assay
95
636
1.80
4.59
11.6
6.1
inr
1.1
1.1
0.16
33
200
(3020779) Urea [Moles/volume] in Serum or Plasma
34
158
2.33
4.53
13.0
8.8
mmol/l
10.3
6.9
1.31
34
151
(3035350) Ketones [Presence] in Urine by Test strip
135
1006
1.74
4.46
6.2
3.2
estimate
0.0
0.0
0.00
29
189
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
83
2.81
4.46
1.4
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
35
3.86
4.42
1.7
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
56
320
1.97
4.41
3.6
3.3
ng/l
75.4
375.4
2.20
27
217
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
65
391
1.90
4.40
1.6
1.3
iu/ml
24.3
25.8
0.07
25
124
(40768443) Skin Pathology biopsy report
21
78
2.85
4.37
1.6
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
135
1010
1.73
4.37
7.9
4.6
estimate
0.0
0.0
0.50
30
191
(3020874) Milk IgE Ab [Units/volume] in Serum
10
22
4.69
4.34
1.1
1.2
u/ml
0.5
0.4
—
5
11
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
55
315
1.96
4.30
2.0
1.6
pmol/l
76000453.4
25000450.5
0.28
50
268
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
7
6
11.95
4.30
7.3
2.0
mg/l
10.0
12.7
—
7
6
(3002173) Hemoglobin [Mass/volume] in Arterial blood
31
142
2.35
4.26
11.3
7.3
g/l
128.4
123.2
0.69
31
137
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
27
4.22
4.20
1.5
1.2
nmol/l
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
135
1017
1.71
4.20
6.2
3.2
estimate
0.0
0.0
0.00
30
181
(3022217) INR in Platelet poor plasma by Coagulation assay
35
171
2.22
4.15
18.2
16.8
inr
1.1
1.3
—
8
32
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
23
4.49
4.12
1.4
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
151
2.28
4.12
3.6
2.7
ml/min/173m2
63.1
70.2
0.52
14
63
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
37
3.65
4.11
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
10
8.22
4.09
2.1
3.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
45
245
2.02
4.05
1.4
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
7
10.24
4.03
1.7
1.6
umol/l
11.1
9.6
—
7
7
(3021901) Oxygen saturation in Capillary blood
11
28
4.06
4.02
3.8
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
28
4.06
4.02
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
14
6.62
4.02
1.1
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
14
6.62
4.02
2.3
3.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
26
114
2.43
3.94
5.1
7.9
kpa
9.3
9.6
0.39
26
106
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
11
7.47
3.89
1.0
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
88
600
1.72
3.88
2.8
2.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
22
91
2.55
3.76
11.4
4.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
25
4.13
3.73
1.6
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
12
6.84
3.70
3.8
5.1
umol/l
24.5
26.9
—
8
12
(3020717) Zinc [Moles/volume] in Serum or Plasma
9
16
5.79
3.69
2.9
1.2
umol/l
29.6
17.3
—
9
16
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
30
3.79
3.68
1.7
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
30
3.79
3.68
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
30
3.79
3.68
4.3
2.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
41
3.29
3.55
1.3
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
17
5.45
3.54
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
107
2.37
3.51
1.7
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
6
10.20
3.51
2.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
327
1.79
3.25
1.7
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
28
3.68
3.23
2.9
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
15
5.47
3.21
1.6
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
15
5.47
3.21
2.6
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
11
6.51
3.20
1.1
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
104
771
1.60
3.19
6.3
3.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
233
2128
2.40
3.17
36.3
11.1
mg/l
20.8
21.6
0.15
198
1583
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
50
307
1.79
3.11
1.8
2.4
mmol/l
2.4
2.4
0.01
43
272
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
34
3.34
3.09
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
85
605
1.61
3.06
1.5
1.4
u/ml
0.5
1.5
2.20
28
167
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
36
200
1.93
3.06
1.5
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
119
918
1.57
3.04
5.0
3.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
12
5.97
3.04
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
88
2.38
3.02
3.0
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
15
57
2.74
3.02
1.9
1.5
u/ml
174.9
249.8
—
10
33
(3026008) Bacteria identified in Urine by Culture
79
555
1.62
2.99
4.1
2.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
5
10.17
2.99
1.2
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
5
5
10.17
2.99
2.0
1.6
umol/l
1.3
1.3
—
5
5
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
5
10.17
2.99
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
81
573
1.61
2.98
2.1
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
75
522
1.62
2.94
7.6
3.3
estimate
0.0
0.0
0.50
30
191
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
30
3.43
2.94
1.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
15
58
2.69
2.93
1.7
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
9
6.80
2.88
1.5
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
9
6.80
2.88
1.5
1.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
5
6
8.47
2.76
1.4
2.7
ug/g
200.2
168.8
—
5
6
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
14
5.11
2.74
1.3
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
192
1673
1.64
2.74
5.1
4.0
pmol/l
14.4
14.5
0.13
181
1546
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
58
386
1.65
2.70
1.4
1.3
u/ml
7.0
10.1
0.30
22
162
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
67
2.48
2.69
1.2
1.1
u/ml
5.8
5.9
—
10
42
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
43
2.88
2.68
1.3
2.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
61
2.55
2.67
1.6
1.3
ug/g
336.9
299.6
—
7
31
(3041096) Erythrocytes [Presence] in Urine by Automated
79
569
1.57
2.66
4.6
2.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
15
4.77
2.61
1.7
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
62
2.51
2.59
1.7
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
29
159
1.93
2.57
7.6
3.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
11
5.56
2.56
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
33
3.11
2.55
1.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
20
96
2.18
2.50
21.6
7.0
mmol/l
25.7
24.7
0.50
20
88
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
21
3.90
2.48
2.9
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
18
84
2.23
2.41
1.2
1.5
u/l
10.4
10.8
0.03
13
59
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
46
2.69
2.39
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
22
3.72
2.38
2.9
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
8
6.35
2.38
1.4
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
5
8
6.35
2.38
1.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
8
6.35
2.38
1.2
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
17
4.20
2.37
1.7
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
23
3.56
2.29
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
23
3.56
2.29
1.6
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
23
3.56
2.29
1.6
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
23
3.56
2.29
1.6
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
13
4.70
2.28
1.2
1.8
%
164.2
141.9
—
6
13
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
29
3.18
2.25
1.7
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
9
5.64
2.22
4.0
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
9
5.64
2.22
4.2
3.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
9
5.64
2.22
1.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
9
5.64
2.22
4.0
2.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
9
5.64
2.22
2.4
1.6
mg/l
4.4
3.0
—
5
9
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
9
5.64
2.22
4.0
2.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
9
5.64
2.22
1.2
1.4
—
—
—
0
0
(4035726)
28
160
1.84
2.21
1.4
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
24
3.41
2.20
1.6
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
24
3.41
2.20
1.6
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
24
3.41
2.20
1.6
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
187
1653
1.52
2.17
4.8
3.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
14
4.36
2.16
4.3
4.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
14
4.36
2.16
1.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
154
1.84
2.14
1.4
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
102
807
1.45
2.11
2.3
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
61
435
1.53
2.11
7.1
3.2
kg/l
1.0
1.0
—
6
64
(3009508) Creatinine [Moles/volume] in Urine
75
559
1.49
2.10
5.0
3.1
mmol/l
7.7
7.8
0.05
69
487
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
10
5.08
2.08
1.2
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
20
3.57
2.07
1.3
1.5
—
—
—
0
0
(44813793)
7
20
3.57
2.07
1.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
15
4.07
2.05
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
57
2.35
2.01
1.3
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
57
2.35
2.01
1.3
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
21
3.40
1.98
3.1
6.1
%
107.7
105.0
—
7
21
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
11
4.61
1.95
1.0
1.1
%
109.0
129.5
—
5
11
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
11
4.61
1.95
1.4
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
16
3.81
1.94
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
39
2.63
1.94
2.7
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
39
255
1.63
1.94
1.3
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
8
28
2.92
1.88
2.1
3.0
%
0.6
1.6
—
8
23
(3021788) Differential panel - Synovial fluid
6
17
3.59
1.85
1.2
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
12
4.23
1.83
1.8
2.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
29
2.82
1.80
1.4
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
140
1.79
1.79
2.3
2.1
e9/l
4.3
3.9
0.29
18
118
(3029075) Extractable nuclear Ab panel - Serum
6
18
3.39
1.75
1.7
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
62
461
1.46
1.74
5.0
3.0
mg/l
2244.7
205.8
0.71
41
292
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
82
2.02
1.74
1.3
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
24
2.97
1.73
1.3
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
7.2
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
7.2
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
7.2
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
7.2
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
83
1.99
1.69
1.3
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
19
3.21
1.67
1.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
14
3.62
1.62
1.4
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
14
3.62
1.62
1.0
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
218
0.48
1.60
1.5
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
85
1.94
1.59
1.3
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
15
3.38
1.53
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
51
2.21
1.53
1.5
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
21
2.90
1.51
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
70
548
1.39
1.46
1.5
1.7
mmol/l
1.4
1.4
0.09
63
484
(3020682) Albumin/Creatinine [Ratio] in Urine
63
485
1.40
1.45
6.0
3.7
mg/mmol
9.2
10.1
0.06
39
297
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
16
3.17
1.44
1.2
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
22
2.77
1.44
1.8
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
40
2.30
1.41
1.8
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
26
167
1.62
1.41
1.3
1.2
—
15.0
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
173
1884
0.73
1.41
4.0
3.6
mmol/l
1.4
1.3
1.50
163
1765
(3013512) EKG study
62
479
1.39
1.40
3.0
3.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
17
2.98
1.36
1.2
1.2
—
72.2
—
0
5
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
42
2.18
1.35
2.4
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
83
1.86
1.34
2.0
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
158
1411
1.33
1.33
6.0
3.2
u/l
44.6
39.0
0.56
151
1346
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
199
1842
1.39
1.31
25.0
10.0
ml/min/173m2
88.9
88.4
0.11
178
1486
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
18
2.81
1.29
1.8
1.4
pg
33.2
32.8
—
5
18
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
77
1.87
1.28
12.4
11.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
156
1.60
1.25
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
36
2.26
1.25
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
37
266
1.46
1.24
2.2
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
209
1959
1.41
1.19
5.8
4.7
mu/l
1.7
2.5
0.64
203
1827
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
26
2.34
1.19
1.0
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
142
1.60
1.19
8.2
7.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
20
2.53
1.15
1.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
177
1903
0.76
1.13
4.6
3.9
mmol/l
5.7
5.8
0.13
170
1774
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
30
2.37
1.13
1.3
1.4
—
—
—
0
0
(4094501)
10
51
2.00
1.13
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
373
1.36
1.05
2.0
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
46
1.99
1.05
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
60
1.87
1.04
6.4
1.8
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
22
2.30
1.04
2.6
2.5
nmol/l
1.1
3.8
—
5
22
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
158
0.55
1.02
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
76
1.75
1.01
1.8
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
70
1.75
0.94
1.8
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
28
2.17
0.92
1.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
79
1.68
0.90
2.5
2.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
56
1.82
0.89
1.2
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
258
0.67
0.84
1.6
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
231
2232
1.46
0.82
22.7
10.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
24
174
1.42
0.80
2.8
3.6
ug/l
18.3
8.2
0.27
17
138
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
18.2
—
1660.6
—
0
25
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
15.4
—
923.8
—
0
25
(3030981) Hyaline casts [#/volume] in Urine by Automated count
15
99
1.55
0.77
2.3
2.3
e6/l
0.2
0.1
0.74
15
94
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
11
171
0.63
0.75
2.3
2.6
ug/l
0.3
0.7
—
6
104
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
189
1985
0.80
0.73
4.9
4.4
mmol/l
2.9
2.8
0.26
181
1864
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
3.2
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
3.2
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
25
2.02
0.73
3.2
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
186
1956
0.81
0.72
4.3
4.0
mmol/l
1.5
1.5
0.38
178
1835
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
26
1.94
0.71
1.6
2.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
26
1.94
0.71
1.6
2.5
mmol/l
103.4
105.8
—
5
26
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
26
1.94
0.71
3.2
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
26
1.94
0.71
3.2
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
26
1.94
0.71
1.6
2.5
mmol/l
4.0
4.0
—
5
26
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
41
1.73
0.70
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
162
1.39
0.69
1.7
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
28
1.80
0.66
1.4
1.2
—
—
—
0
0
(3019225) pH of Specimen
20
146
1.40
0.66
5.3
4.6
—
—
—
0
0
(3044889) 12 lead EKG panel
142
1316
1.18
0.63
4.5
3.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
63
1.61
0.62
8.5
2.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
50
1.62
0.62
3.6
4.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
30
1.68
0.61
1.0
1.6
mmol/l
6.0
7.3
—
5
21
(3039443) Prostate specific Ag panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
201
1927
1.22
0.58
38.3
14.6
g/l
331.7
332.7
0.70
201
1920
(3025130) Human papilloma virus identified in Specimen
6
35
1.73
0.58
1.3
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
134
1.37
0.54
1.4
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
38
1.59
0.54
71.2
6.7
%
65.2
63.9
—
6
38
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
99
0.60
0.53
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
154
1.32
0.50
1.4
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
189
1962
0.85
0.48
4.3
4.0
mmol/l
4.8
4.8
0.13
179
1850
(1761868) Lipid panel - Serum or Plasma
69
767
0.86
0.46
2.2
2.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
157
1.30
0.45
1.3
1.2
—
30.7
—
0
8
(3050129) First trimester maternal screen panel - Serum or Plasma
6
92
0.64
0.43
1.5
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
223
1.24
0.42
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
33
1.53
0.41
3.2
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
5.4
—
2.5
—
0
15
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
9.9
—
0.7
—
0
18
(3023511) Choriogonadotropin [Units/volume] in Urine
10
71
1.43
0.40
1.2
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
37
1.36
0.37
1.6
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
121
0.73
0.36
3.6
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
118
1.29
0.34
2.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
118
1.29
0.34
2.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
119
1.28
0.32
2.3
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
47
1.28
0.32
1.5
1.4
u/l
34.3
21.9
—
6
38
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
92
1.32
0.32
1.5
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
242
2393
1.35
0.29
43.2
17.1
g/l
133.4
135.0
1.15
242
2363
(3035941) MCH [Entitic mass]
242
2391
1.38
0.29
42.6
16.8
pg
29.8
30.0
0.93
242
2363
(3024731) MCV [Entitic volume]
242
2390
1.39
0.29
42.7
16.9
fl
89.8
90.0
0.23
242
2362
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
57
1.23
0.29
1.4
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
112
1.26
0.29
2.4
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
67
1.20
0.26
1.0
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
202
0.83
0.26
8.6
5.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
20
233
0.85
0.25
2.8
3.9
%
20.1
20.5
—
5
102
(3001019) Free T4 and TSH panel - Serum or Plasma
12
147
0.81
0.24
2.2
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
10
0.00
0.21
0.0
3.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
89
1.25
0.21
2.3
2.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
48
1.26
0.20
1.3
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
49
1.23
0.20
1.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
118
1.20
0.19
2.4
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
53
1.14
0.19
1.5
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
64
603
1.08
0.18
1.5
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
26
288
0.89
0.17
3.5
4.3
ug/l
2.1
1.7
0.15
20
255
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
68
0.73
0.17
1.2
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
68
0.73
0.17
1.2
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
70
0.71
0.17
1.2
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
201
2038
0.93
0.14
30.0
12.5
%
40.1
40.0
0.03
162
1635
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
40
425
0.93
0.12
1.7
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
137
0.87
0.12
1.3
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
45
1.11
0.10
85.0
6.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
75
0.80
0.07
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
75
0.80
0.07
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
75
0.80
0.07
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
75
0.80
0.07
1.3
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
83
0.84
0.07
1.1
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
84
0.83
0.07
2.7
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
88
1.02
0.07
2.8
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
258
1.05
0.05
1.6
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
133
1.06
0.01
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
35
356
0.98
0.00
2.5
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
32
319
1.00
0.00
2.4
2.0
—
—
—
0
0
(1002224) Polysomnography panel
10
103
0.97
0.00
1.3
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
225
0.98
0.00
1.8
1.9
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
68
0.88
0.00
1.7
1.6
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
4.7
—
0
6
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
29.8
—
0
6
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
59
0.84
0.00
1.4
1.4
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
98
0.92
0.00
2.7
3.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
2.5
—
0
7
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_COMPLEMENTDEF and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_COMPLEMENTDEF.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: D3_COMPLEMENTDEF – Defects in the complement system

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data